Literature DB >> 7611995

HIV infection decreases intracellular nicotinamide adenine dinucleotide [NAD].

M F Murray1, M Nghiem, A Srinivasan.   

Abstract

We report that HIV-1 infection of human cells in vitro leads to significant decreases in the intracellular concentration of NAD. This decrease varies with viral load and HIV strain. In tissue culture, cells lacking CD4 receptors or cells incubated with heat inactivated virus do not demonstrate this decrease in NAD. Nicotinamide, the amide form of the vitamin niacin, increases intracellular NAD levels in uninfected cells as expected. Our data demonstrate that nicotinamide also maintains increased intracellular NAD concentrations in HIV infected cells. We conclude that HIV induces a state of intracellular pellagra which is reversed by the administration of nicotinamide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611995     DOI: 10.1006/bbrc.1995.1945

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

Review 2.  Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

Authors:  Luis Rajman; Karolina Chwalek; David A Sinclair
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

Review 3.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

Review 4.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 5.  Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.

Authors:  Seon Beom Song; Jin Sung Park; Gu June Chung; In Hye Lee; Eun Seong Hwang
Journal:  Metabolomics       Date:  2019-10-05       Impact factor: 4.290

6.  Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.

Authors:  Livia Vastag; Emre Koyuncu; Sarah L Grady; Thomas E Shenk; Joshua D Rabinowitz
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

7.  The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.

Authors:  Priyesh Bipath; Peter F Levay; Margaretha Viljoen
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

8.  Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.

Authors:  Collin D Heer; Daniel J Sanderson; Lynden S Voth; Yousef M O Alhammad; Mark S Schmidt; Samuel A J Trammell; Stanley Perlman; Michael S Cohen; Anthony R Fehr; Charles Brenner
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

Review 9.  CD38 in the age of COVID-19: a medical perspective.

Authors:  Alberto L Horenstein; Angelo C Faini; Fabio Malavasi
Journal:  Physiol Rev       Date:  2021-03-31       Impact factor: 37.312

Review 10.  Sirtuins Modulation: A Promising Strategy for HIV-Associated Neurocognitive Impairments.

Authors:  Izchel Figarola-Centurión; Martha Escoto-Delgadillo; Gracia Viviana González-Enríquez; Juan Ernesto Gutiérrez-Sevilla; Eduardo Vázquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.